Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.868,89
-0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Italia BIT Sanofi (SANF) Sanofi (SANF) Notizie

Sanofi

SANF
0,00
0,00 (0,00%)
- - Chiuso
Dati in Delay di 15 minuti
Borsa: Italia
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
21/5/202407:30GLOBECommuniqué de presse : Sanofi, Formation Bio et OpenAI..
20/5/202422:54GLOBESanofi: Information concerning the total number of voting..
20/5/202420:15GLOBECommuniqué de presse : Présentation à l’ATS et publication..
13/5/202407:00GLOBEPress Release: Sanofi adds over €1 billion for..
10/5/202408:00GLOBECommuniqué de presse : Sanofi et Novavax concluent un accord..
02/5/202407:00GLOBEPress Release: Beyfortus real-world evidence published in..
30/4/202418:00GLOBEPress Release: Annual General Meeting of April 30, 2024
25/4/202407:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/4/202407:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
17/4/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
12/4/202420:05GLOBESanofi: Information concerning the total number of voting..
08/4/202418:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/3/202407:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
15/3/202420:04GLOBESanofi: Informations relatives au nombre de droits de vote..
11/3/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
24/2/202415:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
23/2/202418:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/2/202407:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
22/2/202419:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
20/2/202423:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202407:00GLOBEPress Release: Japan first in the world to approve Dupixent®..
15/2/202414:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/2/202408:00GLOBECommuniqué de presse : Entraide, conditions de travail..
01/2/202407:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
25/1/202420:30GLOBEPress Release: Dupixent® FDA approved as first and only..
23/1/202407:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
17/1/202422:57GLOBESanofi: Information concerning the total number of voting..
09/1/202407:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
21/12/202307:30GLOBEPress Release: Sanofi announces end of program evaluating..
18/12/202321:59GLOBESanofi: Information concerning the total number of voting..
15/12/202307:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
15/12/202307:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
11/12/202322:08GLOBECommuniqué de presse : Déclaration au sujet de la..
11/12/202301:30GLOBEPress Release: Sarclisa® (isatuximab) plus KRd significantly..
07/12/202307:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202303:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
27/11/202307:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
23/11/202318:00GLOBESanofi: Information concerning the total number of voting..
27/10/202307:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202307:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
22/10/202321:00GLOBECommuniqué de presse : Des résultats de phase III relatifs à..
19/10/202312:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
18/10/202310:45GLOBECommuniqué de presse : Des données de ph III présentées au..
17/10/202320:18GLOBESanofi: Informations relatives au nombre de droits de vote..
13/10/202316:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..
04/10/202307:00GLOBECommuniqué de presse : Sanofi et Teva annoncent une..
03/10/202307:30GLOBEPress Release: Sanofi announces agreement for potential..
26/9/202307:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/9/202309:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/9/202307:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
Apertura: Min: Max:
Chiusura:

La tua Cronologia

BIT
SANF
Sanofi
NASDAQ
FLWS
1 800 Flowers Com
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network